stonks4u
Sign up free
ICCM logo

ICCM IceCure Medical Ltd

NASDAQ Capital Market · Medical - Devices · Healthcare

$3.02
+0.02 (+0.67%)

Headquartered in Caesarea, Israel, and founded in 2006, IceCure Medical Ltd is a medical device enterprise dedicated to inventing, refining, and marketing innovative solutions for treating human tumors through cryoablation, a freezing process. Their primary offering, the ProSense system, provides a specialized cryoablation therapy specifically for breast tumors.

Market Cap: $6.80Mwww.icecure-medical.com

Price (90d)

No price history yet — the daily price refresh runs once a day.

Signal Score (90d)

50
5086122158
Aug 12Aug 13

Quote

Day Range
$2.96 – $3.20
52-Week Range
$2.12 – $42.00
Volume
$49.1K
Market Cap
$6.80M
50-Day Avg
$3.90
200-Day Avg
$13.02
Prev Close
$3.00
Open
$3.08

Valuation & Ratios

P/E Ratio
-2.58
EPS
$-7.10
P/B Ratio
4.28
P/S Ratio
11.48
Debt/Equity
0.02
Current Ratio
2.61
Dividend Yield
+0.0%
Gross Margin
+36.3%

Returns & Efficiency

Return on Equity
-166.4%
Return on Assets
-108.4%
FCF Yield
-37.7%
EV/EBITDA
-2.03

Revenue & Net Income (Annual)

Fiscal YearRevenueNet IncomeEPS
2025$3.38M$-15.06M$-7.10
2024$3.29M$-15.32M$-9.00
2023$3.23M$-14.65M$-9.60
2022$3.08M$-16.98M$-13.69
2021$4.14M$-9.89M$-10.20

Social Signal Score

57
5d
57
3 mentions
—
30d
57
3 mentions
—
60d
57
3 mentions
—
90d
57
3 mentions
—
news: 3

Earnings

Wed, Nov 18(in 3 months)

Consensus estimate $-1.17 per share

2of 7 quarters beat consensus

Typical surprise -8.7% (median, so one quarter with a near-zero estimate can't distort it)

  • Wed, Aug 12$-1.54 vs $-1.52miss
  • Tue, May 12$-1.80 vs $-0.90miss
  • Tue, Mar 17$-1.80 vs $-1.20miss
  • Wed, Nov 19$-0.06 vs $-0.05miss
  • Wed, Aug 13$-0.06 vs $-0.06beat
  • Wed, May 28$-0.06 vs $-0.08beat

Estimates and results for ICCM via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.

Valuation

ICCMhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.

Mentions (3)

  • Newsprnewswire.com·2d ago·Neutral

    …cond publication extends cryoablation's clinical role to axillary lymph node metastases CAESAREA, Israel, Aug. 13, 2026 /PRNewswire/ -- IceCure Medical Ltd. (NASDAQ: ICCM) ("IceCure," "IceCure Medical" or the "Company"), developer of minimally invasive cryoablation technology that destroys tumors by freezing as an option to surgical tumor removal, today highlighted two recent peer-reviewed publications by leading U.S. experts that reinforce the growing clinical role of cryoablation in breast can…

    View source ↗
  • Newsseekingalpha.com·3d ago·Positive

    IceCure Medical Ltd (ICCM) Q2 2026 Earnings Call Transcript IceCure Medical Ltd (ICCM) Q2 2026 Earnings Call Transcript

    View source ↗
  • Newsprnewswire.com·3d ago·Neutral

    IceCure Reports its Financial Results for the First Half of 2026 with 45% Revenue Growth Year-Over-Year The Company is advancing commercial execution and expanding its U.S. commercial footprint through approximately 70% growth in its active installed base following U.S. Food and Drug Administration's ("FDA") clearance, driving long-term value creation and supported by a strong cash position CAESAREA, Israel, Aug. 12, 2026 /PRNewswire/ -- IceCure Medical Ltd. (NASDAQ: ICCM) ("IceCure," "IceCure M

    View source ↗